Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.
SpliceCenter: a suite of web-based bioinformatic applications for evaluating the impact of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based studies.
In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation.
A Postgenomic Visual Icon.
VennMaster: Area-proportional Euler diagrams for functional GO analysis of microarrays.
Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer
Institute Anticancer Drug Screen.
Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers.
MicroRNAs modulate the chemosensitivity of tumor cells.
This web site is a development of the Genomics and Pharmacology Facility, Developmental Therapeutics Branch (DTB), Center for Cancer Research (CCR), National Cancer Institute (NCI).